Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/66629
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMuthuvel, I-
dc.contributor.authorDivyaa, J-
dc.contributor.authorGayathria, P-
dc.contributor.authorBalasundaria, S-
dc.contributor.authorSudhaa, P-
dc.contributor.authorPalanivelc, C-
dc.contributor.authorKrishnakumar, B-
dc.contributor.authorManikandanf, V-
dc.contributor.authorK Alanazig, Abdullah-
dc.contributor.authorThirunarayanan, G-
dc.date.accessioned2025-10-22T11:06:19Z-
dc.date.available2025-10-22T11:06:19Z-
dc.date.issued2025-10-
dc.identifier.issn2583-1321 (Online); 0019-5103 (Print)-
dc.identifier.urihttp://nopr.niscpr.res.in/handle/123456789/66629-
dc.description942-952en_US
dc.description.abstractTwo anilide derivatives have been synthesized with more than 85% yield using FeCl3-bentonite acidic catalyst-supported rearrangement of their oximes. These anilides have been investigated by their physico-chemical constants and spectroscopic data. The effect of various acidic catalysts and solvents on the rearrangement has been studied. The DFT analysis, molecular docking, ADMET properties, and antimicrobial activities of these anilides have been assessed with corresponding ligand protein interaction nature and microbesen_US
dc.language.isoenen_US
dc.publisherNIScPR - CSIRen_US
dc.sourceIJC Vol.64(10) [October 2025]en_US
dc.subjectAnilidesen_US
dc.subjectFeCl3-Bentoniteen_US
dc.subjectIR and NMR spectraen_US
dc.subjectDFT analysisen_US
dc.subjectMolecular dockingen_US
dc.subjectADMET propertiesen_US
dc.subjectAntimicrobial activitiesen_US
dc.titleSynthesis of bioactive aryl anilides using solid acidic FeCl3-Bentonite catalyst: DFT analysis, molecular docking and ADMET property evaluationen_US
dc.identifier.doihttps://doi.org/10.56042/ijc.v64i10.20809en_US
Appears in Collections:IJC Vol.64(10) [October 2025]

Files in This Item:
File Description SizeFormat 
IJC 64(10) 942-952.pdf5.06 MBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.